FLUANXOL

This brand name is authorized in Austria, Canada, Estonia, Finland, France, Germany, Lithuania, Malta, Mexico, Netherlands, Poland, South Africa, Turkey, UK.

Active ingredients

The drug FLUANXOL contains one active pharmaceutical ingredient (API):

1	Flupentixol UNII HAT84MLQ6Z - FLUPENTIXOL DIHYDROCHLORIDE
	Read more about Flupentixol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLUANXOL Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AF01	Flupentixol	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives
Discover more medicines within N05AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02156008, 02156016
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	14335632, 14335649, 14335661, 14335678, 14335684, 17580349, 17580355, 17580361, 17580378, 17580384
EE	Ravimiamet	1005972, 1489765, 1489776
FI	Lääkealan turvallisuus- ja kehittämiskeskus	102017, 102028, 102039
FR	Base de données publique des médicaments	62571671
GB	Medicines & Healthcare Products Regulatory Agency	142367, 142369, 20932, 20936
LT	Valstybinė vaistų kontrolės tarnyba	1003018, 1059629, 1066408
MT	Medicines Authority	MA601/00501
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	401M97
NL	Z-Index G-Standaard	12320218, 13529269
NL	Z-Index G-Standaard, PRK	15105, 17221, 5339, 5347
PL	Rejestru Produktów Leczniczych	100301193, 100301218
TR	İlaç ve Tıbbi Cihaz Kurumu	8699795091076
ZA	Health Products Regulatory Authority	B/2.6.5/1380, G/2.6.5/138